{"id":46964,"date":"2025-08-07T12:52:14","date_gmt":"2025-08-07T10:52:14","guid":{"rendered":"https:\/\/www.oeb.org.cy\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/"},"modified":"2025-08-07T12:52:14","modified_gmt":"2025-08-07T10:52:14","slug":"protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents","status":"publish","type":"post","link":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/","title":{"rendered":"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents"},"content":{"rendered":"<p>The Labour Inspection Department informs all affected parties that on 20 February 2025, the European Commission adopted a Communication establishing an <a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EL\/TXT\/PDF\/?uri=OJ:C_202501150\">Indicative List of dangerous medicines to protect workers from the risks associated with exposure to carcinogens or mutagens at work.<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>The main purpose of the publication of this Indicative List is to further improve the safety of workers exposed to dangerous medicinal products at work as well as to improve the quality of the risk assessment carried out in the workplace where such medicinal products are used and not to replace dangerous medicinal products with medicinal products that are not hazardous or are less hazardous to health. Drug substitution is rarely an option because the intrinsic properties of dangerous drugs are usually necessary for the treatment of the patient and their health should not be compromised by changing them. <\/p>\n<p>&nbsp;<\/p>\n<p>The Indicative List of Dangerous Medicines provides useful information, including on certain cancer medicines used in the healthcare sector to treat a wide range of medical conditions, including cancer.<\/p>\n<p>&nbsp;<\/p>\n<p>It should be noted that the issuance of an Indicative List of Dangerous Medicines cannot replace the mandatory chemical risk assessment of a specific workplace, which must take into account other available information, such as the concentration of a specific substance or more chemicals in the medicines. Therefore, the List can only be considered as an indicative, non-binding and complementary element of the above-mentioned risk assessment. <\/p>\n<p>&nbsp;<\/p>\n<p>This Communication complements the <a href=\"https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/ee1e6d15-4095-11ee-952f-01aa75ed71a1\/language-en\"><em>Guidance<\/em> <em>for<\/em> <em>the<\/em> <em>safe<\/em> <em>management<\/em> <em>of<\/em> <em>hazardous<\/em> <em>medicinal<\/em> <em>products<\/em> <em>at<\/em> <em>work<\/em><\/a> issued by the European Commission in 2023.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Labour Inspection Department informs all affected parties that on 20 February 2025, the European Commission adopted a Communication establishing an Indicative List of dangerous medicines to protect workers from the risks associated with exposure to carcinogens or mutagens at work. &nbsp; The main purpose of the publication of this Indicative List is to further [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":37727,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[62],"tags":[],"class_list":["post-46964","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Protection of workers from exposure to medicines containing carcinogens or mutagenic agents - Cyprus Employers and Industrialists Federation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents - Cyprus Employers and Industrialists Federation\" \/>\n<meta property=\"og:description\" content=\"The Labour Inspection Department informs all affected parties that on 20 February 2025, the European Commission adopted a Communication establishing an Indicative List of dangerous medicines to protect workers from the risks associated with exposure to carcinogens or mutagens at work. &nbsp; The main purpose of the publication of this Indicative List is to further [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/\" \/>\n<meta property=\"og:site_name\" content=\"Cyprus Employers and Industrialists Federation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/oebcy\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-07T10:52:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"webeditorhere\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@oebcy\" \/>\n<meta name=\"twitter:site\" content=\"@oebcy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"webeditorhere\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/\",\"url\":\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/\",\"name\":\"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents - Cyprus Employers and Industrialists Federation\",\"isPartOf\":{\"@id\":\"https:\/\/www.oeb.org.cy\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg\",\"datePublished\":\"2025-08-07T10:52:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.oeb.org.cy\/#\/schema\/person\/ed74887fc5fd9fc0729298b704107341\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#primaryimage\",\"url\":\"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg\",\"contentUrl\":\"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg\",\"width\":700,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.oeb.org.cy\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oeb.org.cy\/#website\",\"url\":\"https:\/\/www.oeb.org.cy\/\",\"name\":\"Cyprus Employers and Industrialists Federation\",\"description\":\"\u039f\u0395\u0392\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oeb.org.cy\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oeb.org.cy\/#\/schema\/person\/ed74887fc5fd9fc0729298b704107341\",\"name\":\"webeditorhere\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.oeb.org.cy\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/eefb79de2b091bd71c4f7218462f0388c3d8fee61f647a3565752c98fe1d66b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/eefb79de2b091bd71c4f7218462f0388c3d8fee61f647a3565752c98fe1d66b8?s=96&d=mm&r=g\",\"caption\":\"webeditorhere\"},\"url\":\"https:\/\/www.oeb.org.cy\/en\/author\/webeditorhere\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents - Cyprus Employers and Industrialists Federation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/","og_locale":"en_US","og_type":"article","og_title":"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents - Cyprus Employers and Industrialists Federation","og_description":"The Labour Inspection Department informs all affected parties that on 20 February 2025, the European Commission adopted a Communication establishing an Indicative List of dangerous medicines to protect workers from the risks associated with exposure to carcinogens or mutagens at work. &nbsp; The main purpose of the publication of this Indicative List is to further [&hellip;]","og_url":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/","og_site_name":"Cyprus Employers and Industrialists Federation","article_publisher":"https:\/\/www.facebook.com\/oebcy\/","article_published_time":"2025-08-07T10:52:14+00:00","og_image":[{"width":700,"height":350,"url":"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg","type":"image\/jpeg"}],"author":"webeditorhere","twitter_card":"summary_large_image","twitter_creator":"@oebcy","twitter_site":"@oebcy","twitter_misc":{"Written by":"webeditorhere","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/","url":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/","name":"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents - Cyprus Employers and Industrialists Federation","isPartOf":{"@id":"https:\/\/www.oeb.org.cy\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#primaryimage"},"image":{"@id":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg","datePublished":"2025-08-07T10:52:14+00:00","author":{"@id":"https:\/\/www.oeb.org.cy\/#\/schema\/person\/ed74887fc5fd9fc0729298b704107341"},"breadcrumb":{"@id":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#primaryimage","url":"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg","contentUrl":"https:\/\/www.oeb.org.cy\/wp-content\/uploads\/2023\/07\/TEE_logo.jpg","width":700,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/www.oeb.org.cy\/en\/protection-of-workers-from-exposure-to-medicines-containing-carcinogens-or-mutagenic-agents\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oeb.org.cy\/en\/"},{"@type":"ListItem","position":2,"name":"Protection of workers from exposure to medicines containing carcinogens or mutagenic agents"}]},{"@type":"WebSite","@id":"https:\/\/www.oeb.org.cy\/#website","url":"https:\/\/www.oeb.org.cy\/","name":"Cyprus Employers and Industrialists Federation","description":"\u039f\u0395\u0392","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oeb.org.cy\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.oeb.org.cy\/#\/schema\/person\/ed74887fc5fd9fc0729298b704107341","name":"webeditorhere","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oeb.org.cy\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/eefb79de2b091bd71c4f7218462f0388c3d8fee61f647a3565752c98fe1d66b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/eefb79de2b091bd71c4f7218462f0388c3d8fee61f647a3565752c98fe1d66b8?s=96&d=mm&r=g","caption":"webeditorhere"},"url":"https:\/\/www.oeb.org.cy\/en\/author\/webeditorhere\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-18 21:18:35","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/posts\/46964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/comments?post=46964"}],"version-history":[{"count":0,"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/posts\/46964\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/media\/37727"}],"wp:attachment":[{"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/media?parent=46964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/categories?post=46964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oeb.org.cy\/en\/wp-json\/wp\/v2\/tags?post=46964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}